Thousand Asian American Study

Hepatitis B Clinical Trial

— TAAS  

Official title:

Thousand Asian American Study (TAAS)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02596438
• Other study ID #: 388325
• Status: Completed
• Phase: N/A
• First received: October 19, 2015
• Last updated: October 27, 2017
• Start date: October 1, 2012
• Est. completion date: September 30, 2017

Study information

• Verified date: October 2017
• Source: University of California, Davis
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The "Thousand Asian American Study" or "TAAS" aims to test 2,000 foreign-born and children of foreign born Asian Americans residing in Sacramento county residents for HBV and (2) counsel at least 90% of those whose screening results are positive for HBV.

Description:

The "Thousand Asian American Study" or "TAAS" aims to better understand the factors associated with testing for hepatitis B viral (HBV) testing among foreign-born Asian and African adult residents of Sacramento county, characteristics of those infected with HBV, and the efficacy of follow-up and linkage to care for those infected with HBV, and develop a research platform for future studies. Thus, what the investigators want to do is 1) test 2000 foreign-born Sacramento county residents for HBV and (2) counsel at least 90% of those whose screening results are positive for HBV. The investigators want to better characterize factors associated with HBV testing and factors that may differentiate those determined to be free of infection, infected with HBV, and those with resulting primary liver cancer.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1076
• Est. completion date: September 30, 2017
• Est. primary completion date: September 30, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• All foreign-born Asians and any foreign-born adults born in CDC-defined high to intermediate endemic areas residing in Sacramento County, California.

Exclusion Criteria:

• Individuals who have been previously serologically tested for Hepatitis B (self-reported).

Related Conditions & MeSH terms

• Hepatitis B

Intervention

Other:
• Hepatitis B
Hepatitis B Surface Antigen, Hepatitis B Surface Antibody and Hepatitis B Core AB, Total Testing

Locations

Country	Name	City	State
United States	University of California, Davis Comprehensive Cancer Center	Sacramento	California

Sponsors (1)

Lead Sponsor	Collaborator
University of California, Davis

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of patients or adult children of patients born in Hepatitis B endemic countries (rate of 2% or higher) getting screened for hepatitis B.		1 year
Secondary	Number of patients that are hepatitis B positive that receive counseling regarding their infection.		1 year